Stay updated on Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The MEDIPLEX Phase I trial record is displayed, detailing the pexidartinib–durvalumab study for advanced pancreatic or colorectal cancer, including its study plan, participant criteria, outcomes, and locations.
    Difference
    46%
    Check dated 2026-11-08T04:45:01.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov site revision changed from v3.7.2 to v3.8.0 while the study page remained unavailable.
    Difference
    0.2%
    Check dated 2026-11-01T01:51:49.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition to using “Super Intelligence” in place of “Artificial Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T01:46:55.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays site revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T01:36:32.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer’s site revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T02:06:43.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The study record page displays a 403 Forbidden message and a Home link instead of study details.
    Difference
    0.5%
    Check dated 2026-10-04T01:52:17.000Z thumbnail image

Stay in the know with updates to Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.